SAN FRANCISCO (MarketWatch) — Pfizer Inc. and Wyeth said late Monday they agreed to divest cetain animal health assets to Boehringer Ingelheim as a result of Pfizer’s pending acquisiiton of Wyeth. Financial terms were not disclosed.
See the original post here:
Pfizer, Wyeth to divest some animal drug assets